Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | Buy | $2.5K | conv 61Unusual sizeFirst in 12mo | SEC | |
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | Award | $2.7K | SEC | ||
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | Award | $16.5K | SEC | ||
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | Award | $17.3K | SEC | ||
Sonnet BioTherapeutics Holdings, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
RENN Fund, Inc.Listing on record | AwardD (derivative) | $55.5K | SEC | ||
RENN Fund, Inc.Listing on record | Buy | $1.8K | conv 38First in 12mo | SEC | |
RENN Fund, Inc.Listing on record | Buy | $650 | conv 46Cluster | SEC | |
RENN Fund, Inc.Listing on record | Buy | $1.2K | conv 56ClusterFirst in 12mo | SEC |